-
What to Watch Today: Dow Set to Bounce After Drop From Record Highs
U.S. stock futures rose Tuesday, a day after market declines from record highs.
-
Stocks Making the Biggest Moves in the Premarket: Albertsons, Zoom Video, Lemonade & More
The stocks making the biggest moves in premarket trading include Albertson’s, Zoom Video, Lemonade, and more.
-
AstraZeneca Covid Vaccine Could Be Distributed Across Europe by Mid-February, EU Official Says
AstraZeneca’s vaccine against the covid-19 could be available across the European Union in mid-February after asking the European Medicines Agency for approval.
-
Israel's Covid Vaccine Rollout Is the Fastest in the World — Here Are Some Lessons for the Rest of Us
From logistics to public information campaigns, there are a number of lessons that other countries could learn from Israel as they try to ramp up their own vaccination drives.
-
WHO Warns Countries Are Helping Covid Thrive Through Inequitable Vaccine Distribution
“There is a clear problem that low and most middle-income countries are not receiving the vaccine yet,” the head of the World Health Organization said.
-
Moderna Coronavirus Vaccine Becomes the Third Approved for Use in the UK
The U.K. has already vaccinated around 1.5 million people.
-
Delaying Second Covid Vaccine Shots Can Be ‘Very Risky,' Says Former FDA Director
It’s risky to delay second doses of vaccines because efficacy data was based on a specific dosing schedule, said former FDA director Norman Baylor.
-
The Covid Vaccine's Long Journey: How Doses Get From the Manufacturing Plant to Your Arm
The Covid vaccine’s distribution involves complex logistics, from cooling it with dry ice to making sure snowstorms don’t delay shipping.
-
Covid Variant Found in South Africa Is Worrying Experts: Here's What We Know So Far
The strain of the coronavirus that has emerged in South Africa is causing concern around the globe.
-
Covid: Red Cross Raffles Super Bowl Tickets to Solicit Convalescent Plasma Donors
The U.S. is recording at least 215,408 new Covid-19 cases and at least 2,664 virus-related deaths each day, based on a seven-day average using JHU data.
-
Israel to Enter Third National Lockdown Despite Successful Covid Vaccination Campaign
Israel braces for a third national lockdown even with the nation seeing success in the rollout of the Pfizer-BioNTech vaccine.
-
UK to Impose Tougher Restrictions on Millions of People as Covid Cases Soar
The U.K. government has added millions of people to its strictest Tier 4 category as coronavirus cases continue to rise.
-
5 Things to Know Before the Stock Market Opens Monday
U.S. stock futures rose Monday after the Dow and S&P 500 closed at record highs on the last day of a tumultuous 2020.
-
Stocks Making the Biggest Moves in the Premarket: Magellan Health, FLIR Systems, Tesla & More
The stocks making the biggest moves in premarket trading include Magellan Health, FLIR Systems, Tesla, and more.
-
What to Watch Today: Wall Street Set to Pick Up Where 2020 Left Off
U.S. stock futures rose Monday after the Dow and S&P 500 closed at record highs on the last day of a tumultuous 2020.
-
UK Rolls Out Oxford-AstraZeneca Vaccine as It Battles Against Covid Surge
The U.K. is rolling out the coronavirus vaccine developed by AstraZeneca and the University of Oxford on Monday.
-
Doctors Criticize UK Health Officials for Changing Pfizer Covid Vaccine Plan
“We have real and grave concerns about these sudden changes to the Pfizer vaccine regime,” the Doctors’ Association UK said on Thursday.
-
Covid Updates: ‘Gilligan's Island' Star Dawn Wells Dies at 82 From Covid Complications
The U.S. is recording at least 188,167 new Covid-19 cases and at least 2,257 virus-related deaths each day, based on a seven-day average using JHU data.
-
Coronavirus Vaccines: Here's What You Need to Know
The vaccination of Americans against the coronavirus has begun, with medical workers, politicians and senior citizens among the first to receive one of two vaccines that have gotten emergency approval in the United States: Pfizer-BioNTech and Moderna. A third vaccine, from AstraZeneca-Oxford, has won emergency approval in the United Kingdom, though results from its trials have raised questions about how…
-
Oxford Researcher Confident Covid Vaccines Can Be Adapted to Protect Against Future Virus Strains
“If we have to make new vaccines, we can make them now that we’ve done the initial work,” Sir John Bell of Oxford University told CNBC.